Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
AZD3293 BACE inhibitor,
LY3314814
2/3 AstraZeneca Amyloid-Related Small Molecule Alzheimer's Disease
Thalidomide Thalomid® 2/3 Celgene Corporation Amyloid-Related, Inflammation Small Molecule Alzheimer's Disease